Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[CRSP](/topic/crsp)

### Top Social Posts

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"JP Morgan China Healthcare: Key takeaways from 11th batch of national centralized drug procurement Full report in bio $ZLAB $IMAB $AKESO $EGRNF $HLVX $ALNY $ARWR $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI $FATE $ADVM $VERV $PRAX $GLPG"  
[X Link](https://x.com/Biobeats99/status/1983494188692836663) [@Biobeats99](/creator/x/Biobeats99) 2025-10-29T11:20Z XXX followers, XXX engagements


"Thats one I started adding little to this week. Its high risk bro strictly added because the pipeline and theres been multiple insider buys. If you want my higher conviction biotechs. Theyre $crsp $twst $absi $rxrx $ilmn These I see big growth in post quantum plays like $laes also"  
[X Link](https://x.com/Cryptobruhdd/status/1983291326662942947) [@Cryptobruhdd](/creator/x/Cryptobruhdd) 2025-10-28T21:54Z XXX followers, XXX engagements


"Discord: $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"  
[X Link](https://x.com/stocket_rocket/status/1983271921413435812) [@stocket_rocket](/creator/x/stocket_rocket) 2025-10-28T20:37Z XX followers, XXX engagements


"$SGMO $CRSP $EDIT $NTLA $BEAM $PGEN $QURE $BIIB $BMRN $LLY Sangamo's liquidity has been a focal point with analysts noting a "cash crunch" risk if partnerships falter. Current projections of funding into Q4 2025: Supported by $38.3M cash (Q2 end) plus ongoing collaboration revenues (e.g. from Eli Lilly capsid license in Q1 2025 which provided $18M upfront). $SGMO needs an extension to 2026 which is contingent on non-dilutive sources. The company is in advanced negotiations for a Fabry commercialization deal potentially yielding upfront/milestone payments to fund BLA submission (Q1 2026) and"  
[X Link](https://x.com/yusufhameed/status/1983194867111997796) [@yusufhameed](/creator/x/yusufhameed) 2025-10-28T15:31Z 1714 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

CRSP

Top Social Posts

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"JP Morgan China Healthcare: Key takeaways from 11th batch of national centralized drug procurement Full report in bio $ZLAB $IMAB $AKESO $EGRNF $HLVX $ALNY $ARWR $IONS $BLUE $BMRN $SRPT $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $DNLI $FATE $ADVM $VERV $PRAX $GLPG"
X Link @Biobeats99 2025-10-29T11:20Z XXX followers, XXX engagements

"Thats one I started adding little to this week. Its high risk bro strictly added because the pipeline and theres been multiple insider buys. If you want my higher conviction biotechs. Theyre $crsp $twst $absi $rxrx $ilmn These I see big growth in post quantum plays like $laes also"
X Link @Cryptobruhdd 2025-10-28T21:54Z XXX followers, XXX engagements

"Discord: $CRSP $PRGO $OGN $ELAN $ZTS $ROIV $BHC $MYL $AMRX $CORT $IRWD $SUPN $LGND $PCRX $KRTX $ACAD $ARVN $BLUE $AGIO $FOLD $SAGE $XENE $PTCT $VNDA $ZGNX $AERI $ANAB $AVIR $BPMC $CLVS $DCPH $EBS $ENDP $EPZM $ESPR $GERN $GWPH $HRTX $INVA"
X Link @stocket_rocket 2025-10-28T20:37Z XX followers, XXX engagements

"$SGMO $CRSP $EDIT $NTLA $BEAM $PGEN $QURE $BIIB $BMRN $LLY Sangamo's liquidity has been a focal point with analysts noting a "cash crunch" risk if partnerships falter. Current projections of funding into Q4 2025: Supported by $38.3M cash (Q2 end) plus ongoing collaboration revenues (e.g. from Eli Lilly capsid license in Q1 2025 which provided $18M upfront). $SGMO needs an extension to 2026 which is contingent on non-dilutive sources. The company is in advanced negotiations for a Fabry commercialization deal potentially yielding upfront/milestone payments to fund BLA submission (Q1 2026) and"
X Link @yusufhameed 2025-10-28T15:31Z 1714 followers, XXX engagements

CRSP
/topic/crsp/posts